Atossa Therapeutics, Inc. (ATOS)
2.33
-0.07
(-2.92%)
USD |
NASDAQ |
Sep 18, 13:11
Atossa Therapeutics Price : 2.33 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | 2.42 | 2.43 | 2.37 | 2.40 | 33289.00 |
| Sep 16, 2026 | 2.39 | 2.48 | 2.39 | 2.42 | 45777.00 |
| Sep 15, 2026 | 2.475 | 2.49 | 2.37 | 2.37 | 43779.00 |
| Sep 14, 2026 | 2.53 | 2.555 | 2.45 | 2.48 | 35040.00 |
| Sep 11, 2026 | 2.36 | 2.54 | 2.36 | 2.51 | 60410.00 |
| Sep 10, 2026 | 2.36 | 2.61 | 2.33 | 2.34 | 47238.00 |
| Sep 09, 2026 | 2.54 | 2.54 | 2.40 | 2.40 | 24800.00 |
| Sep 08, 2026 | 2.49 | 2.587 | 2.445 | 2.515 | 41370.00 |
| Sep 04, 2026 | 2.51 | 2.60 | 2.50 | 2.52 | 28028.00 |
| Sep 03, 2026 | 2.50 | 2.60 | 2.46 | 2.53 | 56692.00 |
| Sep 02, 2026 | 2.40 | 2.51 | 2.39 | 2.46 | 44772.00 |
| Sep 01, 2026 | 2.48 | 2.50 | 2.317 | 2.42 | 92004.00 |
| Aug 31, 2026 | 2.57 | 2.590 | 2.50 | 2.50 | 53195.00 |
| Aug 28, 2026 | 2.62 | 2.62 | 2.50 | 2.58 | 49003.00 |
| Aug 27, 2026 | 2.64 | 2.69 | 2.585 | 2.64 | 23115.00 |
| Aug 26, 2026 | 2.66 | 2.70 | 2.61 | 2.65 | 26302.00 |
| Aug 25, 2026 | 2.62 | 2.69 | 2.58 | 2.68 | 49690.00 |
| Aug 24, 2026 | 2.56 | 2.65 | 2.45 | 2.64 | 57150.00 |
| Aug 21, 2026 | 2.59 | 2.62 | 2.51 | 2.54 | 25656.00 |
| Aug 20, 2026 | 2.62 | 2.62 | 2.44 | 2.59 | 70955.00 |
| Aug 19, 2026 | 2.57 | 2.76 | 2.55 | 2.64 | 62197.00 |
| Aug 18, 2026 | 2.77 | 2.783 | 2.565 | 2.59 | 58564.00 |
| Aug 17, 2026 | 2.62 | 2.970 | 2.55 | 2.79 | 192438.0 |
| Aug 14, 2026 | 2.54 | 2.69 | 2.430 | 2.60 | 96120.00 |
| Aug 13, 2026 | 2.36 | 2.56 | 2.355 | 2.56 | 83113.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Immix Biopharma, Inc. | 12.41 |
| ACADIA Pharmaceuticals, Inc. | 26.95 |
| Alnylam Pharmaceuticals, Inc. | 241.95 |
| Anika Therapeutics, Inc. | 20.69 |
| Savara, Inc. | 5.33 |
Price Related Metrics
| PEG Ratio | -0.0040 |
| Price to Book Value | 0.8667 |
| Earnings Yield | -186.5% |
| Market Cap | 23.25M |
| PEGY Ratio | -0.0040 |